These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8209 related articles for article (PubMed ID: 17547717)

  • 1. Establishment and characterization of a cell line (DEOC-1) originating from a human malignant melanoma of the skin.
    Maeshima S; Yamada T; Kiyokane K; Mori H
    Hum Cell; 2007 May; 20(2):23-38. PubMed ID: 17547717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary.
    Yamada T; Hattori K; Satomi H; Okazaki T; Mori H; Hirose Y
    J Ovarian Res; 2016 Jun; 9(1):32. PubMed ID: 27259990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of a cell line (OMC-9) originating from a human endometrial stromal sarcoma.
    Kakuno Y; Yamada T; Mori H; Narabayashi I
    Hum Cell; 2008 May; 21(2):46-55. PubMed ID: 18397474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A newly established melanoma cell line (GAK) with 5-S-cysteinyldopa phenotype].
    Nozawa S; Ohta H; Tsukazaki K; Udagawa Y; Kurihara S; Kano S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jun; 36(6):883-92. PubMed ID: 6431036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of human vaginal malignant melanoma xenotransplants.
    Sawada M; Terada N; Nishizawa Y; Ito S; Wakamatsu K; Takemura K; Yamamoto T; Ozaki M; Sakamoto H; Tanizawa O
    Anticancer Res; 1994; 14(4A):1477-82. PubMed ID: 7526770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary.
    Yamada T; Ueda M; Otsuki Y; Ueki M; Sugimoto O
    Gynecol Oncol; 1991 Feb; 40(2):118-28. PubMed ID: 2010102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a novel Chinese metastatic melanoma cell line showing the new cytogenetic and biological properties.
    Yi X; Zhu G; Li Y; Liu Y; Luan Q; Dai W; Wang L; Liao W; Gao T; Li C
    Cell Biol Int; 2015 Apr; 39(4):508-14. PubMed ID: 25639772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of melanoma cell line derived from malignant melanoma of human uterine cervix.
    Kiguchi K; Ishiwata I; Ishiwata C; Tokieda Y; Iguchi M; Suzuki R; Saga M; Ishikawa H
    Hum Cell; 1998 Jun; 11(2):93-100. PubMed ID: 9777403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance.
    Krumm A; Barckhausen C; Kücük P; Tomaszowski KH; Loquai C; Fahrer J; Krämer OH; Kaina B; Roos WP
    Cancer Res; 2016 May; 76(10):3067-77. PubMed ID: 26980768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a melanoma cell line with metastatic characteristics.
    Enjoji M; Nakashima M; Sakai H; Nawata H
    Hum Cell; 1995 Sep; 8(3):115-20. PubMed ID: 8652447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment and characterization of a melanoma cell line HME1].
    Wu SH; Huang BY; Gu HH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):181-3. PubMed ID: 16145907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro.
    Aubert C; Rougé F; Galindo JR
    J Natl Cancer Inst; 1980 May; 64(5):1029-40. PubMed ID: 6929009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment and characterization of a human malignant schwannoma cell line (HKMS)].
    Ono I; Ishiwata I; Nakaguchi T; Soma M; Tokita N; Ishiwata C; Mukai M; Nozawa S; Ishikawa H
    Hum Cell; 1989 Sep; 2(3):272-7. PubMed ID: 2519215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human malignant melanoma heterotransplanted to nude mice.
    Tropé C; Johnsson JE; Alm P; Landberg T; Olsson H; Wennerberg J
    Neoplasma; 1981; 28(5):585-91. PubMed ID: 7312076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
    Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
    Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans.
    Thomas-Pfaab M; Annereau JP; Munsch C; Guilbaud N; Garrido I; Paul C; Brousset P; Lamant L; Meyer N
    J Dermatol Sci; 2013 Feb; 69(2):105-13. PubMed ID: 23219141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a transplantable tumor line (RMM) and cell line (RMM-C) from a malignant amelanotic melanoma in the F344 rat, with particular reference to galectin-3 expression in vivo and in vitro.
    Bondoc A; Katou-Ichikawa C; Golbar HM; Tanaka M; Izawa T; Kuwamura M; Yamate J
    Histol Histopathol; 2016 Nov; 31(11):1195-207. PubMed ID: 26949998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of a highly-metastatic model of human primary melanoma of the small intestine orthotopically transplanted in the small intestine of nude mice].
    Tuo CW; Zhang N; Liu QZ; Yang B; Wang MY
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):885-90. PubMed ID: 19173986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of a new human cell-line (AMOC-2) derived from a serous adenocarcinoma of ovary.
    Yabushita H; Ueno N; Sawaguchi K; Higuchi K; Noguchi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):888-94. PubMed ID: 2794621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 411.